About this policy
The comment period for the MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells DL38566 Local Coverage Determination (LCD) began on 4/23/20 and ended on 7/7/20. The notice period for L38566 begins on 6/10/21 and will become effective on 7/25/21. The title of the LCD was revised from MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells to MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.